Entering text into the input field will update the search result below

Harte-Hanks jumps 4% as BMO upgrades to Outperform, pointing to dividend

Jul. 21, 2015 10:42 AM ETHarte Hanks, Inc. (HHS) StockHHSBy: Jason Aycock, SA News Editor
  • Harte-Hanks (NYSE:HHS) is up 4% as BMO Capital points to its dividend yield (and a possible buyback) in upgrading shares to Outperform, from Market Perform.
  • Analyst Daniel Salmon has a price target of $7 on the stock; it closed yesterday at $4.95 and is currently trading at $5.16.
  • The stock's felt pressure this month due to a lack of strategic update since CEO Robert Philpott exited his post, Salmon says, but despite challenged fundamentals, "the risk/reward is incrementally positive."
  • "Most importantly –- and in part due to high inside ownership -– we believe the current dividend is safe, and it’s also currently yielding just short of 7%," he says. "Moreover, we believe there is increased likelihood of some nominal share buyback; our main question would be if management would consider incremental borrowing (either on bank facilities or issuance of new debt) or simply use excess FCF."
  • A management-led LBO isn't out of the question either, he says: Interim CEO and current CFO Doug Shepard has experience taking companies private.

Recommended For You

More Trending News

About HHS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
HHS--
Harte Hanks, Inc.